Breaking News, Collaborations & Alliances

CEPI & CureVac Announce $34M Partnership

For the ongoing development of The RNA Printer prototype—a transportable, down-scaled, automated messenger RNA (mRNA) printing facility

The Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG have announced a partnership agreement worth up to $34 million for the ongoing development of The RNA Printer prototype—a transportable, down-scaled, automated messenger RNA (mRNA) printing facility.    This platform will provide a rapid supply of lipid-nanoparticle (LNP)-formulated mRNA vaccine candidates that can target known pathogens (including Lassa Fever, Yellow Fever, and Rabies) and prepare for rapid respon...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters